Amazon is reportedly mulling on expanding its business in Japan and entering the prescription drug market there. The e-commerce and tech firm is said to be planning to team up with small to mid-sized pharmacies for the project.
According to Nikkei Asia, some sources who are familiar with the project shared that Amazon may launch a new prescription service through partnerships with the local pharmacies in the Asian nation. They added that this is likely to be established starting next year when electronic prescriptions are set to be allowed in Japan for the first time.
The sources opined that if Amazon pushes through with this plan of jumping into the prescription drug sales business, this move could be a turning point for the local brick-and-mortar pharmacies in Japan.
This is because, with the application of Amazon’s cutting-edge ordering and distribution system, customers in the country will be able to have their medicines delivered right on the steps of their homes instead of going out to buy them in pharmacy stores.
To operate the business, Amazon will join forces with local pharmacies and set up a platform where patients can find instructions online - on how to take their medications. In any case, the prices of prescription drugs in Japan are usually set by the government, while the distribution system is in shambles since there are 70 wholesalers across the country, and the number of pharmacies has already reached 60,000.
Thus, if Amazon will enter the country’s prescription drug market, it will be able to offer a more organized distribution system as well. This means that patients and consumers will be able to receive their medicines in a timely and orderly manner.
Meanwhile, Fox Business further reported that the new prescription service may be launched next year and through Amazon, pharmacies in Japan will be able to sell medicines directly to patients online since Japan will start allowing electronic prescriptions in the country by that time. People may obtain virtual prescriptions on Amazon’s platform after receiving professional medical care online.


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 



